Interview: Jassy Wang – CEO, MegaPro Biomedical, Taiwan

Jassy Wang, CEO of MegaPro Biomedical, a nanomedicine development company specializing in developing nanoparticles and nanomicelles, discusses the evolving nanomedicine market in Taiwan and reveals the company’s plans for future growth. Can you introduce MegaPro Biomedical to our readers?
"Nanosize features many advantages; amongst them I would highlight the ability for the passive targeting of the cancer site. Additionally, anti-cancer drugs’ strong side effects can be reduced."
Become a PharmaBoardroom Member for free to access this content
Join the 20,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Already a member? Sign In

Related Interviews

Latest Report